This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Maryland Board of Pharmacy | |
|---|---|
| Name | Maryland Board of Pharmacy |
| Formed | 1924 |
| Jurisdiction | Maryland |
| Headquarters | Annapolis, Maryland |
| Chief1 name | Executive Director |
| Parent agency | Maryland Department of Health |
Maryland Board of Pharmacy is the state agency charged with licensure, regulation, and discipline of pharmacists, pharmacies, and related permit holders in Maryland. It functions within the statutory framework established by the Maryland General Assembly and coordinates with state and federal entities including the U.S. Drug Enforcement Administration, Centers for Medicare & Medicaid Services, and the Food and Drug Administration to implement pharmacy practice standards. The Board interacts with professional organizations such as the American Pharmacists Association, National Association of Boards of Pharmacy, and academic institutions including the University of Maryland School of Pharmacy.
The Board traces its origins to early 20th-century reforms following national movements influenced by figures such as Harvey Washington Wiley and legislative milestones like the Pure Food and Drug Act of 1906. Throughout the 20th century the Board evolved alongside regulatory developments exemplified by the Food, Drug, and Cosmetic Act and the creation of the U.S. Drug Enforcement Administration; major changes in scope paralleled actions taken in states such as New York and California. In the 1990s and 2000s, technological advances driven by vendors like Cerner Corporation and policy shifts following events such as the Opioid epidemic in the United States prompted the Board to expand monitoring and continuing education requirements, aligning with standards from the National Association of Boards of Pharmacy and accreditation bodies like the Accreditation Council for Pharmacy Education.
The Board operates under statutory authority established by the Maryland Pharmacy Act and is administratively attached to the Maryland Department of Health. Governance features appointed members drawn from licensed practitioners, public representatives, and legal professionals, analogous to boards in Pennsylvania and Virginia. Executive leadership liaises with the Office of the Attorney General of Maryland for disciplinary prosecutions and consults with educational programs at Johns Hopkins University and Towson University for workforce development. The Board convenes committees on matters comparable to committees of the National Association of Boards of Pharmacy and interacts with insurers such as Blue Cross Blue Shield Association and federal programs like Medicare for reimbursement and compliance guidance.
Statutory duties include licensing pharmacists and pharmacies, promulgating regulations, and adjudicating disciplinary cases under standards consistent with decisions from courts including the Maryland Court of Appeals. The Board enforces laws derived from the Maryland Annotated Code, coordinates with the Drug Enforcement Administration on controlled substances, and implements federal requirements from the Centers for Disease Control and Prevention and the Substance Abuse and Mental Health Services Administration. It issues guidance mirroring national policies from the American Society of Health-System Pharmacists, and adopts standards influenced by organizations such as Institute for Safe Medication Practices and Joint Commission.
The Board administers pharmacist licensure pathways including examinations such as the North American Pharmacist Licensure Examination and credentials recognized alongside programs at University of Maryland School of Pharmacy and Philadelphia College of Pharmacy. It registers facilities including community pharmacies, institutional pharmacies, and specialty compounding pharmacies, applying standards similar to those in Texas and Florida. Requirements reference training programs accredited by the Accreditation Council for Pharmacy Education and background checks coordinated with agencies like the Federal Bureau of Investigation and the Maryland State Police.
Inspections follow protocols consistent with federal inspections by the Food and Drug Administration and the Drug Enforcement Administration. Enforcement actions include fines, suspensions, and revocations adjudicated through processes comparable to administrative hearings in the Maryland Office of Administrative Hearings and appeals to the Maryland Court of Special Appeals. The Board collaborates with local health departments such as the Baltimore City Health Department and professional groups including the American Pharmacists Association when conducting investigations that may involve entities like CVS Health, Walgreens Boots Alliance, and independent pharmacy chains.
The Board administers policies relating to controlled substances in coordination with the U.S. Drug Enforcement Administration and adopts prescribing and dispensing guidelines informed by federal initiatives such as the Comprehensive Addiction and Recovery Act and the Support for Patients and Communities Act. It oversees the state’s prescription monitoring program which exchanges data with regional databases and national systems promoted by the National Association of Boards of Pharmacy and integrates with health information exchanges like CRISP (Chesapeake Regional Information System for our Patients). The Board’s rules intersect with statutes influenced by litigation and public health responses tied to events such as the Opioid epidemic in the United States and policy reforms advocated by organizations like American Medical Association and Drug Policy Alliance.
The Board provides consumer-facing services including licensure verification, complaint intake, and public advisories paralleling efforts by agencies such as the Federal Trade Commission on deceptive practices. It issues recalls and safety alerts in consultation with the Food and Drug Administration and communicates with stakeholders including patient advocacy groups like National Alliance on Mental Illness, AARP, and local non-profits. Outreach and education align with campaigns from the Centers for Disease Control and Prevention and professional societies such as the American Pharmacists Association to promote safe medication use, and coordination with programs like Medicaid ensures consumer protections for vulnerable populations.